JPX · 3544.T
Satudora Holdings Co.,Ltd.
¥1,246-¥1 (-0.08%)
Satudora Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
Loading market information…
JPX · 2689.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
OLBA HEALTHCARE HOLDINGS, Inc.’s forward annual dividend is ¥80 per share, paid annual. The forward yield is 4.17% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
OLBA HEALTHCARE HOLDINGS, Inc.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow OLBA HEALTHCARE HOLDINGS, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
OLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institutions, corporate research laboratories, individuals, and elderly care providers. The company's operations span several key areas. Its Medical Equipment business acts as a wholesale distributor for a wide array of advanced medical devices. This includes prosthetic and implantable items such as artificial joints, pacemakers, and coronary stents; surgical tools like steel instruments and ultrasonic scalpels; and diagnostic imaging systems such, as MRI and CT scanners. Additionally, they supply essential hospital equipment, including respirators, intraoperative monitors, and surgical lighting. In the realm of life sciences, OLBA HEALTHCARE offers specialized reagents and apparatus for genetic research, cell culture, and protein analysis. They also provide automated analyzers for biochemistry, immunology, and blood diagnostics, along with various testing reagents. Furthermore, the company performs dedicated DNA analysis services. The Supply Processing and Distribution (SPD) business supports clients by managing inventory, information, and procurement functions efficiently. Finally, the Nursing Care Products business focuses on enhancing the well-being of those requiring care. This segment offers rental services for nursing care equipment and sells welfare aids such as portable toilets and bathing solutions. They are also involved in managing a program designed to facilitate comfortable long-term care at home, referred to as "long-term care reform." The company rebranded from Kawanishi Holdings, Inc. to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,246-¥1 (-0.08%)
Satudora Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
¥578-¥9 (-1.53%)
Japan Medical Dynamic Marketing, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.49% below the high.
¥2,161+¥63 (+3.0%)
Techno Medica Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.46% below the high.
¥1,438-¥8 (-0.55%)
Colan Totte.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.9% below the high.
¥418+¥2 (+0.48%)
Daiken Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.52% below the high.
¥585-¥2 (-0.34%)
GENOVA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.33% below the high.
¥930¥0 (0.0%)
DVx Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.21% below the high.
¥3,475-¥25 (-0.71%)
Yamashita Health Care Holdings,Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
